Akbar Ali Khan Pathan
Research Subjects
Akbar Ali Khan Pathan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Bhavana Panthi
Department of Pharmacoinformatics, National Institute of Pharmaceutical Education and Research, Hajipur, India
1 shared publicationCr Kaundinya
Consultant Clinical Scientist, Bayt Al Hiqma, Abu Dhabi, United Arab Emirates
1 shared publicationJilani Purusottapatnam Shaik
Genome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh
1 shared publicationMaha Arafah
Department of Pathology, College of Medicine, King Saud University, Riyadh
1 shared publicationMohammad Alanazi
Genome Research Chair (GRC), Department of Biochemistry, College of Science, King Saud University, Kingdom of Saudi Arabia
1 shared publication- Mukesh Chourasia
Center for Computational Biology and Bioinformatics, Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida 201301, India
1 shared publication
Latest Publications
- Open Access
Association of genetic variants from the Wnt signaling pathway with cardiovascular disease in the Saudi Arabian population
The canonical Wnt/β-catenin signaling pathway plays a key role in cardiovascular development, preservation, and pathology. Variations in critical Wnt pathway genes may influence an individual’s susceptibility to cardiovascular disease (CVD), although data from specific populations are scarce. In this case–control study, we analyzed 15 single-nucleotide polymorphisms (SNPs) within eight Wnt pathway genes (APC, AXIN2, LRP6, CTNNB1, TCF7L2, DKK3, DKK4, and SFRP3) among 151 CVD patients and 129 healthy controls. We examined the genotypic and allelic distributions for correlations with CVD risk utilizing odds ratios, confidence intervals, and chi-square tests, while controlling for age and gender. We discovered that the APC variants rs459552 and rs454886 conferred protective effects, with age-and gender-dependent variation. AXIN2 SNP rs11079571 made men more likely to get CVD, and rs3923086 made people over 58 more susceptible. The DKK4 variant rs3763511 was associated with an elevated risk of cardiovascular disease, particularly among males and older individuals (age M/F). In SFRP3, rs7775 was associated with an elevated risk in older individuals (age M/F), whereas rs288326 showed a protective effect. For LRP6, rs2284396 increased the risk of CVD in females, while rs2075241 conferred protection in males. We did not identify significant associations for the CTNNB1, TCF7L2, or DKK3 variants. The present data indicate that specific Wnt pathway variants are associated with cardiovascular disease risk, contingent on age and gender. To verify these outcomes and determine whether these variants can serve as genetic markers of cardiovascular disease risk, larger, more diverse studies with whole genome sequencing approach is necessary.
Open AccessAssociation of genetic variants from the Wnt signaling pathway with cardiovascular disease in the Saudi Arabian population
The canonical Wnt/β-catenin signaling pathway plays a key role in cardiovascular development, preservation, and pathology. Variations in critical Wnt pathway genes may influence an individual’s susceptibility to cardiovascular disease (CVD), although data from specific populations are scarce. In this case–control study, we analyzed 15 single-nucleotide polymorphisms (SNPs) within eight Wnt pathway genes (APC, AXIN2, LRP6, CTNNB1, TCF7L2, DKK3, DKK4, and SFRP3) among 151 CVD patients and 129 healthy controls. We examined the genotypic and allelic distributions for correlations with CVD risk utilizing odds ratios, confidence intervals, and chi-square tests, while controlling for age and gender. We discovered that the APC variants rs459552 and rs454886 conferred protective effects, with age-and gender-dependent variation. AXIN2 SNP rs11079571 made men more likely to get CVD, and rs3923086 made people over 58 more susceptible. The DKK4 variant rs3763511 was associated with an elevated risk of cardiovascular disease, particularly among males and older individuals (age M/F). In SFRP3, rs7775 was associated with an elevated risk in older individuals (age M/F), whereas rs288326 showed a protective effect. For LRP6, rs2284396 increased the risk of CVD in females, while rs2075241 conferred protection in males. We did not identify significant associations for the CTNNB1, TCF7L2, or DKK3 variants. The present data indicate that specific Wnt pathway variants are associated with cardiovascular disease risk, contingent on age and gender. To verify these outcomes and determine whether these variants can serve as genetic markers of cardiovascular disease risk, larger, more diverse studies with whole genome sequencing approach is necessary.
- Open Access
- 1 May 2016
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. 9, 2575-2584
Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches
Objective: Kirsten rat sarcoma (K-Ras) protein is a member of Ras family belonging to the small guanosine triphosphatases superfamily. The members of this family share a conserved structure and biochemical properties, acting as binary molecular switches. The guanosine triphosphate-bound active K-Ras interacts with a range of effectors, resulting in the stimulation of downstream signaling pathways regulating cell proliferation, differentiation, and apoptosis. Efforts to target K-Ras have been unsuccessful until now, placing it among high-value molecules against which developing a therapy would have an enormous impact. K-Ras transduces signals when it binds to guanosine triphosphate by directly binding to downstream effector proteins, but in case of guanosine diphosphate-bound conformation, these interactions get disrupted. Methods: In the present study, we targeted the nucleotide-binding site in the “on” and “off” state conformations of the K-Ras protein to find out suitable lead compounds. A structure-based virtual screening approach has been used to screen compounds from different databases, followed by a combinatorial fragment-based approach to design the apposite lead for the K-Ras protein. Results: Interestingly, the designed compounds exhibit a binding preference for the “off” state over “on” state conformation of K-Ras protein. Moreover, the designed compounds’ interactions are similar to guanosine diphosphate and, thus, could presumably act as a potential lead for K-Ras. The predicted drug-likeness properties of these compounds suggest that these compounds follow the Lipinski’s rule of five and have tolerable absorption, distribution, metabolism, excretion and toxicity values. Conclusion: Thus, through the current study, we propose targeting only “off” state conformations as a promising strategy for the design of reversible inhibitors to pharmacologically inhibit distinct conformations of K-Ras protein.
- 1 May 2016
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. 9, 2575-2584
Open AccessLead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches
Objective: Kirsten rat sarcoma (K-Ras) protein is a member of Ras family belonging to the small guanosine triphosphatases superfamily. The members of this family share a conserved structure and biochemical properties, acting as binary molecular switches. The guanosine triphosphate-bound active K-Ras interacts with a range of effectors, resulting in the stimulation of downstream signaling pathways regulating cell proliferation, differentiation, and apoptosis. Efforts to target K-Ras have been unsuccessful until now, placing it among high-value molecules against which developing a therapy would have an enormous impact. K-Ras transduces signals when it binds to guanosine triphosphate by directly binding to downstream effector proteins, but in case of guanosine diphosphate-bound conformation, these interactions get disrupted. Methods: In the present study, we targeted the nucleotide-binding site in the “on” and “off” state conformations of the K-Ras protein to find out suitable lead compounds. A structure-based virtual screening approach has been used to screen compounds from different databases, followed by a combinatorial fragment-based approach to design the apposite lead for the K-Ras protein. Results: Interestingly, the designed compounds exhibit a binding preference for the “off” state over “on” state conformation of K-Ras protein. Moreover, the designed compounds’ interactions are similar to guanosine diphosphate and, thus, could presumably act as a potential lead for K-Ras. The predicted drug-likeness properties of these compounds suggest that these compounds follow the Lipinski’s rule of five and have tolerable absorption, distribution, metabolism, excretion and toxicity values. Conclusion: Thus, through the current study, we propose targeting only “off” state conformations as a promising strategy for the design of reversible inhibitors to pharmacologically inhibit distinct conformations of K-Ras protein.